SHARE IN FOCUS: Redcare Pharmacy with another high – Metzler relies on e-prescription

FRANKFURT (dpa-AFX) – After a buy recommendation from Bankhaus Metzler, the shares of Redcare Pharmacy (Redcare Pharmacy (ex Shop Apotheke)) reached another high in two years at 137.40 euros on Friday. The online pharmacy papers gained 3.3 percent and have more than tripled in the current year. DocMorris also rose in Switzerland on Friday.

Like many colleagues, Metzler analyst Felix Dennl relies on e-prescriptions as a major growth driver. As of January 1, 2024, use of prescription medications will be mandatory in Germany. A bumpy introduction phase with many delays ends.

The digitalization Overall, the German healthcare system is making progress. The National Agency for Digital Medicine (Gematik) has created the formal requirements for the use of digital identities in the healthcare system. From the beginning of 2024, health insurance companies will be obliged to provide their insured persons with a health ID upon request.

Dennl assumes that the e-prescription will receive a real boost in 2025 when clinicians are also obliged to use it. The expert also referred to a study by Julius Lagodny entitled “Medicine supply on the brink: Why children are poorly cared for and pharmacies are dying”. According to this, 1.2 million seniors over the age of 65 will be without a pharmacy in their zip code by 2030. According to Dennl, this underlines the opportunities for online pharmacies./ag/bek/mis

Selected leverage products on DocMorris

With knock-outs, speculative investors can participate disproportionately in price movements. Simply select the lever you want and we will show you suitable open-end products on DocMorris

Advertising

ttn-28